Biblio
“Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
, “A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 783-796, 2018.
, “A Systematic Review and Meta-Analysis of On-Road Simulator and Cognitive Driving Assessment in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 713-29, 2016.
, “A Systematic Review and Meta-Analysis of the Association between Helicobacterpylori Infection and Dementia.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1431-42, 2016.
, “A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1471-1481, 2018.
, “A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1359-1379, 2017.
, “Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1.”, J Alzheimers Dis, vol. 89, no. 1, pp. 283-297, 2022.
, “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
, “Tai Chi Chuan and Baduanjin Increase Grey Matter Volume in Older Adults: A Brain Imaging Study.”, J Alzheimers Dis, vol. 60, no. 2, pp. 389-400, 2017.
, “Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 3, pp. 889-911, 2017.
, “Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.
, “A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
, “TAR DNA-Binding Protein 43 Is Associated with Rate of Memory and Functional and Global Cognitive Decline in the Decade Prior to Death.”, J Alzheimers Dis, vol. 80, no. 2, pp. 683-693, 2021.
, “Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1587-1597, 2018.
, “Targeted Metabolomic Analysis of Soluble Lysates from Platelets of Patients with Mild Cognitive Impairment and Alzheimer's Disease Compared to Healthy Controls: Is PC aeC40:4 a Promising Diagnostic Tool?”, J Alzheimers Dis, vol. 57, no. 2, pp. 493-504, 2017.
, “Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.”, J Alzheimers Dis, vol. 64, no. s1, pp. S23-S31, 2018.
, “Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.”, J Alzheimers Dis, vol. 64, no. s1, pp. S427-S453, 2018.
, “Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 271-6, 2016.
, “Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
, “Tau Acetylation in Entorhinal Cortex Induces its Chronic Hippocampal Propagation and Cognitive Deficits in Mice.”, J Alzheimers Dis, vol. 77, no. 1, pp. 241-255, 2020.
, “Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 509-513, 2018.
, “Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 4, pp. 965-75, 2015.
, “Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk.”, J Alzheimers Dis, vol. 72, no. 2, pp. 641-652, 2019.
, “Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.”, J Alzheimers Dis, vol. 67, no. 2, pp. 447-467, 2019.
, “Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation.”, J Alzheimers Dis, vol. 64, no. s1, pp. S535-S546, 2018.
,